Register Now – Live with Leadership with NIH Directors

Content From: HIV.govPublished: April 22, 20212 min read


Live with Leadership Webinar - May 10, 2021, 1 PM

On Monday, May 10th the Office of Infectious Disease and HIV/AIDS Policy (OIDP) is holding a Live with Leadership conversation about how NIH-supported research can help us end HIV in the United States. Joining Harold Phillips, Chief Operating Officer for EHE and Senior HIV Advisor at OIDP, for the conversation will be:

  • Dr. Carl Dieffenbach, Director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, who will discuss NIH’s portfolio of EHE implementation science research projects.
  • Dr. Nora Volkow, Director of the National Institute on Drug Abuse, who will discuss NIDA’s HIV-related research.

The session will be held from 1:00 – 1:45 p.m. (ET).

Register NowExit Disclaimer

The Live with Leadership conversations provide community opportunities to hear directly from key HHS and HIV community leaders about new and ongoing work to further the goals of the Ending the HIV Epidemic (EHE) initiative. The first session in 2021 featured updates from the HIV Research for Prevention ConferenceExit Disclaimer. In 2020, the series included conversations held during AIDS 2020Exit Disclaimer, the National 2020 National Ryan White Conference on HIV Care and TreatmentExit Disclaimer,  the U.S. Conference on HIV/AIDS (USCHA)Exit Disclaimer and a special World AIDS DayExit Disclaimer edition. Conversations in this series are approximately 20 minutes in length and a great way to hear about EHE and key findings from HIV conferences.

Monday, May 10th, 2021
1:00 – 1:45 pm (ET)
Click hereExit Disclaimer to register.

Registration is required for the Live with Leadership session. This event is open to everyone, please note capacity is limited so register early! This webinar will be recorded and will be available after the session for those unable to attend.

To receive timely updates on EHE, upcoming Live with Leadership sessions and more from, follow our social media channels (FacebookExit Disclaimer, TwitterExit Disclaimer, and InstagramExit Disclaimer) and sign up for updates.